Hepatic Extracellular Volume Fraction by CMR: A Novel Prognostic Marker in Tricuspid Regurgitation
Hepatic ECV is a novel prognostic marker that provides incremental risk stratification in TR and has potential to impact therapeutic decision-making in the era of expanded treatment options for TR.
Authors
- Pablo Villar Calle (ORCID: https://orcid.org/0000-0001-7249-7667)
- Nicholas Chan (ORCID: https://orcid.org/0000-0002-8765-7798)
- Edmund Naami (ORCID: https://orcid.org/0000-0001-7447-1452)
- Pascal Spincemaille (ORCID: https://orcid.org/0000-0002-8821-1341)
- Yu Wang (ORCID: https://orcid.org/0000-0003-3151-0778)
- Mahniz Reza
- Jiwon Kim
- Lorenzo Sewanan
- Elizabeth Manowitz
- Robert S. Zhang
- Jonathan W. Weinsaft
Institutions
- Dartmouth–Hitchcock Medical Center (US)
- Cornell University (US)
Publication Details
- Journal
- Circulation Cardiovascular Imaging
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1161/circimaging.125.018988
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 23.38